What is the added value of combined core biopsy and fine needle aspiration in the diagnostic process of renal tumours?

Abstract

PurposeNon-diagnostic results still hinder the routine use of core biopsy (CB) and fine needle aspiration (FNA) in the diagnostic process of renal tumours. Furthermore, substantial interobserver variability has been reported. We assessed the added value of combining the results of CB and FNA by five pathologists in the ex vivo diagnosis of renal mass.MethodsTwo ex vivo core biopsies were taken followed by two FNA passes from extirpated tumours. All samples were evaluated by five blinded pathologists. A consensus diagnosis of the surgical specimen was the index for comparison. For each pathologist, the number of non-diagnostic (non-conclusive or undetermined biology and failed biopsies), correct and incorrect scored cases of each technique was assessed. When a non-diagnostic CB or FNA had a correct diagnostic counterpart, this was considered as of added value.ResultsOf the 57 assessed tumours, 53 were malignant. CB was non-diagnostic in 4–10 cases (7–17.5%). FNA established the correct diagnosis in 1–7 of these cases.FNA was non-diagnostic in 2–6 cases (3.5–10.5%), and the counterpart CB established the correct diagnosis in 1–6 of these cases.For the 5 pathologists, accuracy of CB and FNA varied between 82.5–93% and 89.5–96.5%, respectively. Combination of both types of biopsy resulted in 55–57 correct results (accuracy 96.5–100%), i.e., an increase in accuracy of 3.5–14%.ConclusionCombining the result of CB and FNA in renal mass biopsy leads to a higher diagnostic accuracy. Recommendations on which technique used should be adapted to local expertise and logistic possibilities.

Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasis

“…Several studies have been performed by means of fluorescence in situ hybridization, and one field of research is aimed at defining which set of alterations can be held as "typical" of specific tumor subtypes. Anyway, this procedure is still investigational [16,[18][19][20][21].…”

Ancillary studies in fine needle aspiration of the kidney

“…Although FNA is both accurate and sufficient for diagnosing most common RCCs, most of the unusual RCCs require additional tissue for testing, meaning that the use of cell blocks and core needle biopsies are likely to become more critical, primarily to ensure adequate tissue for testing …”

Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization

“…Recent studies indicate that 10–25% of core needle biopsies are rendered non‐diagnostic by histology alone . Biopsies obtained by fine needle aspiration (FNA) have higher diagnostic rates, although with reduced accuracy . Hence, there is a compelling need to develop ancillary assays that could assist in the accurate classification of SRMs, guiding subsequent patient management.…”